Law360 (November 9, 2018, 3:22 PM EST) -- A three-judge panel in the Ninth Circuit has sided with Boiron Inc., affirming its victory in a suit brought by buyers who claimed the company's homeopathic pills did not provide relief for flu symptoms and that the company falsely advertised the pills' capabilities.
The Ninth Circuit on Thursday found that Boiron presented adequate evidence to convince the jury that its pills worked as advertised and that there was no plain error in how the jury arrived at its verdict.
The suit, filed in 2013, alleges Boiron misrepresented the health benefits of Oscillococcinum in violation of California's Unfair Competition Law and Consumer...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!